Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMBTL2M)

Drug Name

TP-1454 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Pyruvate kinase M2 (PKM)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
CAP-232	DMR6LXM	Renal cell carcinoma	2C90	Phase 2a	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT04328740) Phase 1 Study of Oral TP-1454. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Sumitomo Dainippon Pharma.
3	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.